Purchasing Medical Innovation: The Right Technology, for the Right Patient, at the Right Price
Innovation in medical technology generates a remarkable supply of new drugs, devices, and diagnostics that improve health, reduce risks, and extend life. But these technologies are too often used on the wrong patient, in the wrong setting, or at an unaffordable price. The only way to moderate the growth in health care costs without undermining the dynamic of medical innovation is to improve the process of assessing, pricing, prescribing, and using new technologies. Purchasing Medical Innovation analyzes the contemporary revolution in the purchasing of health care technology, with a focus on the roles of the Food and Drug Administration (FDA), Medicare and private health insurers, physicians and hospitals, and consumers themselves. The FDA is more thoroughly assessing product performance under real-world conditions as well as in laboratory settings, accelerating the path to market for breakthroughs while imposing use controls on risky products. Insurers are improving their criteria for coverage and designing payment methods that reward efficiency in the selection of new treatments. Hospitals are aligning adoption of complex supplies and equipment more closely with physiciansÕ preferences for the best treatment for their patients. Consumers are becoming more engaged and financially accountable for their health care choices. This book describes both the strengths and deficiencies of the current system of purchasing and highlights opportunities for buyers, sellers, and users to help improve the value of medical technology: better outcomes at lower cost.
What people are saying - Write a review
We haven't found any reviews in the usual places.
Regulatory Access to the Market
Insurance Coverage and Reimbursement
prices paid by Medicare and
Methods of Payment for Medical Technology
Variance across hospitals in prices paid for implantable
The Hospital as Purchaser
Other editions - View all
agency ambulatory ambulatory surgery centers angioplasty approved benefits cardiac Centers of Excellence clinical trials coinsurance comparative effectiveness competition contract copayments cover coverage decisions coverage policy defibrillators developed device price diagnostic disease drug-eluting stents drugs efficient England Journal episode payments evidence expensive facilities FDA’s Fountain Valley Health Affairs hospital’s implantable devices improve incentives increased innovation insurance designs interventions joint replacement Jude Medical Center Kaiser Permanente knee limit list price Long Beach Memorial manufacturers market access medical devices medical group medical management medical staff medical technology Medicare Medicare’s ment national coverage offer operating room orthopedic surgery osteoarthritis outcomes patients payment methods percent performance physicians physicians and hospitals postmarket surveillance premarket private insurers procedures programs providers rates reduce regulatory reimbursement require risks service lines suppliers surgeons surgical TAVR technology assessment committee technology firms therapy tion ucts value-based valve replacement